(Q35562015)

8 August 2017

1 reference

title

Oxidative stress in uremia (English)

1 reference

8 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

22 March 2024

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

22 March 2024

1

Jonathan Himmelfarb

1 reference

8 August 2017

Raymond M. Hakim

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14564195

22 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14564195

22 March 2024

publication date

1 November 2003

1 reference

full work available at URL

8 August 2017

https://journals.lww.com/00041552-200311000-00004

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Current Opinion in Nephrology and Hypertension

22 March 2024

published in

1 reference

8 August 2017

volume

12

1 reference

8 August 2017

issue

6

1 reference

8 August 2017

page(s)

593-598

1 reference

Premature cardiovascular disease in chronic renal failure

8 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors

22 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

22 March 2024

3

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein

22 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Reactive oxygen species, mitochondria, apoptosis and aging.

22 March 2024

5

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

The NADPH oxidase of endothelial cells

22 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

22 March 2024

Myeloperoxidase

8

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide

22 March 2024

9

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

22 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Enhanced LDL oxidation in uremic patients: an additional mechanism for accelerated atherosclerosis?

22 March 2024

12

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Role of reactive aldehyde in cardiovascular diseases

22 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

22 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

22 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Thiol-based antioxidants.

22 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

22 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure

22 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes

22 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

22 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Elevated plasma F2-isoprostanes in patients on long-term hemodialysis

22 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

22 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Breath ethane in dialysis patients and control subjects

22 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Oxidative cross-linking of ApoB100 and hemoglobin results in low density lipoprotein modification in blood. Relevance to atherogenesis caused by hemodialysis.

22 March 2024

25

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency

22 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia

22 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

22 March 2024

30

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients

22 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity

22 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment

22 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Oxidative stress and haemodialysis: role of inflammation and duration of dialysis treatment

22 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

The antioxidants of human extracellular fluids

22 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Albumin--an important extracellular antioxidant?

22 March 2024

37

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure. Evidence of increased oxidative stress in malnourished patients.

22 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.

22 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Induction of protein oxidation by intravenous iron in hemodialysis patients: role of inflammation

22 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

22 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

22 March 2024

43

1 reference

https://api.crossref.org/works/10.1097/00041552-200311000-00004

22 March 2024

Identifiers

1 reference

8 August 2017

1 reference